Interim Analysis of Investigator-Initiated Phase 2 Trial of Siltuximab in Treatment of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Related to CAR T-Cell Therapy

Autor: Narkhede, Mayur, Stasi, Antonio Di, Bal, Susan, Shea, Lauren K, Goyal, Gaurav, Sledge, Alexandria, Hardwick, Pamela, Giri, Smith, Mehta, Amitkumar
Zdroj: Transplantation and Cellular Therapy; February 2023, Vol. 29 Issue: 2, Number 2 Supplement 1 pS133-S134, 2p
Databáze: Supplemental Index